EASL – The Digital International Liver Congress 2020
August 27-29, 2020
ENYO Pharma was connected from the 27th to the 29th of August at the digital EASL International Liver Congress and present 2 posters.
“Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”Download the poster (PDF)
“A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”Download the poster (PDF)